Loading…

Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs

The bronchodilator and cardiovascular effects of NKH477 (6-(3-dimethylaminopropionyl)forskolin hydrochloride) were evaluated. In anesthetized guinea pigs, i.v. bolus injections of NKH477 (1-100 μg/kg) inhibited the bronchoconstriction induced by inhaled leukotriene D4, increased the heart rate (HR)...

Full description

Saved in:
Bibliographic Details
Published in:Japanese Journal of Pharmacology 1995, Vol.68(3), pp.245-253
Main Authors: Iida, Masashi, Fujita, Naomi, Hosono, Makoto, Sukenaga, Yoshikazu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23
cites cdi_FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23
container_end_page 253
container_issue 3
container_start_page 245
container_title Japanese Journal of Pharmacology
container_volume 68
creator Iida, Masashi
Fujita, Naomi
Hosono, Makoto
Sukenaga, Yoshikazu
description The bronchodilator and cardiovascular effects of NKH477 (6-(3-dimethylaminopropionyl)forskolin hydrochloride) were evaluated. In anesthetized guinea pigs, i.v. bolus injections of NKH477 (1-100 μg/kg) inhibited the bronchoconstriction induced by inhaled leukotriene D4, increased the heart rate (HR) and decreased the diastolic arterial blood pressure (DBP) in a dose-dependent manner. The bronchodilator effect of NKH477 was 1500 times more potent than that of aminophylline and 17 times less potent than that of isoproterenol. The selectivity of NKH477 for bronchodilation vs an increase in HR was 15 times higher than that of isoproterenol and similar to that of aminophylline; and vs a decrease in DBP, the selectivity was 4 times higher than that of aminophylline and similar to that of isoproterenol. I.v. infusion of NKH477 (0.1-3 μg/kg/min) for 2 hr dose-dependently inhibited the bronchoconstriction induced by i.v. histamine. Isoproterenol (0.1 μg/kg/min, i.v.) enhanced the bronchoconstriction after termination of the infusion, whereas NKH477 did not. In conscious guinea pigs, inhalation of NKH477 (0.1-5 mg/ml) concentration-dependently inhibited the bronchoconstriction induced by inhaled histamine, and a high concentration of NKH477 (35.4 mg/ml) increased the HR. The bronchodilator effect of inhaled NKH477 was 15 times less potent than that of isoproterenol. The selectivity of inhaled NKH477 was similar to that of isoproterenol. These results indicate that NKH477 may be useful as a bronchodilator.
doi_str_mv 10.1254/jjp.68.245
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77525960</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021519819354885</els_id><sourcerecordid>77525960</sourcerecordid><originalsourceid>FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23</originalsourceid><addsrcrecordid>eNptkU1v1DAQhiMEKkvhwh3JB8QBNYu_kxzLttsiqoIEiKPldSZdBzde7GQl_j2zyrInDvbImlePR88UxWtGl4wr-aHvd0tdL7lUT4oFE7IqhaL6abGglLNSsaZ-XrzIucdnTZk8K84qWUklq0URP6Y4uG1sfbBjTMQOLVnZ1Pq4t9lNwSZy3XXgxkxiR-4_38qquiCW3Mc9BPLTjpDKbzFMmwBkHVP-FYMfyBUkv7ej38MFwefN5Aew5Kt_yC-LZ50NGV4d63nxY339fXVb3n25-bS6vCudrsVYagfcar6pWAsN01IKPEpbwetOOmW5E61uXSPahlFn61aCqhvXUSlqV224OC_ezdxdir8nyKN59NlBCHaAOGVTVYqrRlMMvp-DLsWcE3Rml_yjTX8Mo-Zg16Bdo2uDdjH85kidNo_QnqJHndh_e-yjPBu6ZAfn8ykmNOWKS4yt5xgyPObigNLA9HFKA0oxrtN9H3fBsKZRhlJdU4GFG4pD4KVEQxvNDqCrGdTn0T7A6SObRu8CEnfbzBrFDvOL-ToQ_rXd1iYDA2LkjAHcyN5DMtl5GBxOl3D1po3-fzb-AqrIwc4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77525960</pqid></control><display><type>article</type><title>Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs</title><source>ScienceDirect</source><creator>Iida, Masashi ; Fujita, Naomi ; Hosono, Makoto ; Sukenaga, Yoshikazu</creator><creatorcontrib>Iida, Masashi ; Fujita, Naomi ; Hosono, Makoto ; Sukenaga, Yoshikazu ; Nippon Kayaku Co ; Research and Development Division ; Ltd ; Pharmaceuticals Group</creatorcontrib><description>The bronchodilator and cardiovascular effects of NKH477 (6-(3-dimethylaminopropionyl)forskolin hydrochloride) were evaluated. In anesthetized guinea pigs, i.v. bolus injections of NKH477 (1-100 μg/kg) inhibited the bronchoconstriction induced by inhaled leukotriene D4, increased the heart rate (HR) and decreased the diastolic arterial blood pressure (DBP) in a dose-dependent manner. The bronchodilator effect of NKH477 was 1500 times more potent than that of aminophylline and 17 times less potent than that of isoproterenol. The selectivity of NKH477 for bronchodilation vs an increase in HR was 15 times higher than that of isoproterenol and similar to that of aminophylline; and vs a decrease in DBP, the selectivity was 4 times higher than that of aminophylline and similar to that of isoproterenol. I.v. infusion of NKH477 (0.1-3 μg/kg/min) for 2 hr dose-dependently inhibited the bronchoconstriction induced by i.v. histamine. Isoproterenol (0.1 μg/kg/min, i.v.) enhanced the bronchoconstriction after termination of the infusion, whereas NKH477 did not. In conscious guinea pigs, inhalation of NKH477 (0.1-5 mg/ml) concentration-dependently inhibited the bronchoconstriction induced by inhaled histamine, and a high concentration of NKH477 (35.4 mg/ml) increased the HR. The bronchodilator effect of inhaled NKH477 was 15 times less potent than that of isoproterenol. The selectivity of inhaled NKH477 was similar to that of isoproterenol. These results indicate that NKH477 may be useful as a bronchodilator.</description><identifier>ISSN: 0021-5198</identifier><identifier>EISSN: 1347-3506</identifier><identifier>DOI: 10.1254/jjp.68.245</identifier><identifier>PMID: 7474547</identifier><identifier>CODEN: JJPAAZ</identifier><language>eng</language><publisher>Kyoto: The Japanese Pharmacological Society</publisher><subject>Animals ; Biological and medical sciences ; Blood pressure ; Blood Pressure - drug effects ; Bronchodilator ; Bronchodilator Agents - pharmacology ; Colforsin - analogs &amp; derivatives ; Colforsin - pharmacology ; Dose-Response Relationship, Drug ; Guinea Pigs ; Heart rate ; Heart Rate - drug effects ; Injections, Intravenous ; Male ; Medical sciences ; Muscle, Smooth, Vascular - drug effects ; NKH477 ; Pharmacology. Drug treatments ; Respiratory system ; Time Factors ; Vasodilator Agents - pharmacology</subject><ispartof>The Japanese Journal of Pharmacology, 1995, Vol.68(3), pp.245-253</ispartof><rights>1995 Elsevier B.V.</rights><rights>The Japanese PharmacologicalSociety</rights><rights>1995 INIST-CNRS</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23</citedby><cites>FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021519819354885$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,4024,27923,27924,27925,45780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3602524$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7474547$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iida, Masashi</creatorcontrib><creatorcontrib>Fujita, Naomi</creatorcontrib><creatorcontrib>Hosono, Makoto</creatorcontrib><creatorcontrib>Sukenaga, Yoshikazu</creatorcontrib><creatorcontrib>Nippon Kayaku Co</creatorcontrib><creatorcontrib>Research and Development Division</creatorcontrib><creatorcontrib>Ltd</creatorcontrib><creatorcontrib>Pharmaceuticals Group</creatorcontrib><title>Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs</title><title>Japanese Journal of Pharmacology</title><addtitle>Jpn.J.Pharmacol.</addtitle><description>The bronchodilator and cardiovascular effects of NKH477 (6-(3-dimethylaminopropionyl)forskolin hydrochloride) were evaluated. In anesthetized guinea pigs, i.v. bolus injections of NKH477 (1-100 μg/kg) inhibited the bronchoconstriction induced by inhaled leukotriene D4, increased the heart rate (HR) and decreased the diastolic arterial blood pressure (DBP) in a dose-dependent manner. The bronchodilator effect of NKH477 was 1500 times more potent than that of aminophylline and 17 times less potent than that of isoproterenol. The selectivity of NKH477 for bronchodilation vs an increase in HR was 15 times higher than that of isoproterenol and similar to that of aminophylline; and vs a decrease in DBP, the selectivity was 4 times higher than that of aminophylline and similar to that of isoproterenol. I.v. infusion of NKH477 (0.1-3 μg/kg/min) for 2 hr dose-dependently inhibited the bronchoconstriction induced by i.v. histamine. Isoproterenol (0.1 μg/kg/min, i.v.) enhanced the bronchoconstriction after termination of the infusion, whereas NKH477 did not. In conscious guinea pigs, inhalation of NKH477 (0.1-5 mg/ml) concentration-dependently inhibited the bronchoconstriction induced by inhaled histamine, and a high concentration of NKH477 (35.4 mg/ml) increased the HR. The bronchodilator effect of inhaled NKH477 was 15 times less potent than that of isoproterenol. The selectivity of inhaled NKH477 was similar to that of isoproterenol. These results indicate that NKH477 may be useful as a bronchodilator.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Bronchodilator</subject><subject>Bronchodilator Agents - pharmacology</subject><subject>Colforsin - analogs &amp; derivatives</subject><subject>Colforsin - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Guinea Pigs</subject><subject>Heart rate</subject><subject>Heart Rate - drug effects</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>NKH477</subject><subject>Pharmacology. Drug treatments</subject><subject>Respiratory system</subject><subject>Time Factors</subject><subject>Vasodilator Agents - pharmacology</subject><issn>0021-5198</issn><issn>1347-3506</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNptkU1v1DAQhiMEKkvhwh3JB8QBNYu_kxzLttsiqoIEiKPldSZdBzde7GQl_j2zyrInDvbImlePR88UxWtGl4wr-aHvd0tdL7lUT4oFE7IqhaL6abGglLNSsaZ-XrzIucdnTZk8K84qWUklq0URP6Y4uG1sfbBjTMQOLVnZ1Pq4t9lNwSZy3XXgxkxiR-4_38qquiCW3Mc9BPLTjpDKbzFMmwBkHVP-FYMfyBUkv7ej38MFwefN5Aew5Kt_yC-LZ50NGV4d63nxY339fXVb3n25-bS6vCudrsVYagfcar6pWAsN01IKPEpbwetOOmW5E61uXSPahlFn61aCqhvXUSlqV224OC_ezdxdir8nyKN59NlBCHaAOGVTVYqrRlMMvp-DLsWcE3Rml_yjTX8Mo-Zg16Bdo2uDdjH85kidNo_QnqJHndh_e-yjPBu6ZAfn8ykmNOWKS4yt5xgyPObigNLA9HFKA0oxrtN9H3fBsKZRhlJdU4GFG4pD4KVEQxvNDqCrGdTn0T7A6SObRu8CEnfbzBrFDvOL-ToQ_rXd1iYDA2LkjAHcyN5DMtl5GBxOl3D1po3-fzb-AqrIwc4</recordid><startdate>1995</startdate><enddate>1995</enddate><creator>Iida, Masashi</creator><creator>Fujita, Naomi</creator><creator>Hosono, Makoto</creator><creator>Sukenaga, Yoshikazu</creator><general>The Japanese Pharmacological Society</general><general>Japanese Pharmacological Society</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1995</creationdate><title>Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs</title><author>Iida, Masashi ; Fujita, Naomi ; Hosono, Makoto ; Sukenaga, Yoshikazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Bronchodilator</topic><topic>Bronchodilator Agents - pharmacology</topic><topic>Colforsin - analogs &amp; derivatives</topic><topic>Colforsin - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Guinea Pigs</topic><topic>Heart rate</topic><topic>Heart Rate - drug effects</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>NKH477</topic><topic>Pharmacology. Drug treatments</topic><topic>Respiratory system</topic><topic>Time Factors</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>online_resources</toplevel><creatorcontrib>Iida, Masashi</creatorcontrib><creatorcontrib>Fujita, Naomi</creatorcontrib><creatorcontrib>Hosono, Makoto</creatorcontrib><creatorcontrib>Sukenaga, Yoshikazu</creatorcontrib><creatorcontrib>Nippon Kayaku Co</creatorcontrib><creatorcontrib>Research and Development Division</creatorcontrib><creatorcontrib>Ltd</creatorcontrib><creatorcontrib>Pharmaceuticals Group</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese Journal of Pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iida, Masashi</au><au>Fujita, Naomi</au><au>Hosono, Makoto</au><au>Sukenaga, Yoshikazu</au><aucorp>Nippon Kayaku Co</aucorp><aucorp>Research and Development Division</aucorp><aucorp>Ltd</aucorp><aucorp>Pharmaceuticals Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs</atitle><jtitle>Japanese Journal of Pharmacology</jtitle><addtitle>Jpn.J.Pharmacol.</addtitle><date>1995</date><risdate>1995</risdate><volume>68</volume><issue>3</issue><spage>245</spage><epage>253</epage><pages>245-253</pages><issn>0021-5198</issn><eissn>1347-3506</eissn><coden>JJPAAZ</coden><abstract>The bronchodilator and cardiovascular effects of NKH477 (6-(3-dimethylaminopropionyl)forskolin hydrochloride) were evaluated. In anesthetized guinea pigs, i.v. bolus injections of NKH477 (1-100 μg/kg) inhibited the bronchoconstriction induced by inhaled leukotriene D4, increased the heart rate (HR) and decreased the diastolic arterial blood pressure (DBP) in a dose-dependent manner. The bronchodilator effect of NKH477 was 1500 times more potent than that of aminophylline and 17 times less potent than that of isoproterenol. The selectivity of NKH477 for bronchodilation vs an increase in HR was 15 times higher than that of isoproterenol and similar to that of aminophylline; and vs a decrease in DBP, the selectivity was 4 times higher than that of aminophylline and similar to that of isoproterenol. I.v. infusion of NKH477 (0.1-3 μg/kg/min) for 2 hr dose-dependently inhibited the bronchoconstriction induced by i.v. histamine. Isoproterenol (0.1 μg/kg/min, i.v.) enhanced the bronchoconstriction after termination of the infusion, whereas NKH477 did not. In conscious guinea pigs, inhalation of NKH477 (0.1-5 mg/ml) concentration-dependently inhibited the bronchoconstriction induced by inhaled histamine, and a high concentration of NKH477 (35.4 mg/ml) increased the HR. The bronchodilator effect of inhaled NKH477 was 15 times less potent than that of isoproterenol. The selectivity of inhaled NKH477 was similar to that of isoproterenol. These results indicate that NKH477 may be useful as a bronchodilator.</abstract><cop>Kyoto</cop><pub>The Japanese Pharmacological Society</pub><pmid>7474547</pmid><doi>10.1254/jjp.68.245</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-5198
ispartof The Japanese Journal of Pharmacology, 1995, Vol.68(3), pp.245-253
issn 0021-5198
1347-3506
language eng
recordid cdi_proquest_miscellaneous_77525960
source ScienceDirect
subjects Animals
Biological and medical sciences
Blood pressure
Blood Pressure - drug effects
Bronchodilator
Bronchodilator Agents - pharmacology
Colforsin - analogs & derivatives
Colforsin - pharmacology
Dose-Response Relationship, Drug
Guinea Pigs
Heart rate
Heart Rate - drug effects
Injections, Intravenous
Male
Medical sciences
Muscle, Smooth, Vascular - drug effects
NKH477
Pharmacology. Drug treatments
Respiratory system
Time Factors
Vasodilator Agents - pharmacology
title Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A26%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bronchodilator%20and%20Cardiovascular%20Effects%20of%20NKH477,%20a%20Novel%20Water-Soluble%20Forskolin%20Derivative,%20in%20Guinea%20Pigs&rft.jtitle=Japanese%20Journal%20of%20Pharmacology&rft.au=Iida,%20Masashi&rft.aucorp=Nippon%20Kayaku%20Co&rft.date=1995&rft.volume=68&rft.issue=3&rft.spage=245&rft.epage=253&rft.pages=245-253&rft.issn=0021-5198&rft.eissn=1347-3506&rft.coden=JJPAAZ&rft_id=info:doi/10.1254/jjp.68.245&rft_dat=%3Cproquest_cross%3E77525960%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c683t-6ce2a62b71de91644364456a328f4c5a2c3d6dc93d910ca8d4e589cf0438c7b23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77525960&rft_id=info:pmid/7474547&rfr_iscdi=true